Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02306161
Title Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Ewing sarcoma

Therapies

Cyclophosphamide + Doxorubicin + Etoposide + Ifosfamide + Vincristine Sulfate

Ganitumab

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.